|
|
|
Volumn 29, Issue 3, 2004, Pages 113-127
|
|
Natriuretic peptides and the management of heart failure.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATRIAL NATRIURETIC FACTOR;
ENDOTHELIAL NITRIC OXIDE SYNTHASE;
INDUCIBLE NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE;
NOS2A PROTEIN, HUMAN;
NOS3 PROTEIN, HUMAN;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL;
CONGESTIVE HEART FAILURE;
DISEASE MODEL;
DRUG EFFECT;
ENZYMOLOGY;
HEART MUSCLE;
HUMAN;
METABOLISM;
REVIEW;
TREATMENT OUTCOME;
ANIMALS;
ATRIAL NATRIURETIC FACTOR;
DISEASE MODELS, ANIMAL;
HEART FAILURE, CONGESTIVE;
HUMANS;
MYOCARDIUM;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE II;
NITRIC OXIDE SYNTHASE TYPE III;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 16544379529
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (157)
|
